enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Omega-3 acid ethyl esters - Wikipedia

   en.wikipedia.org/wiki/Omega-3_acid_ethyl_esters

   Omega-3 acid ethyl esters are used in addition to changes in diet to reduce triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia. [10] In the European Union and other major markets outside the US, omega-3 acid ethyl esters are indicated for hypertriglyceridemia by itself, or in combination with a statin for people with mixed dyslipidemia.

3. Ethyl eicosapentaenoic acid - Wikipedia

   en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

   Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL. Further, it is often required to be used with a statin (maximally ...

4. Omega-3 carboxylic acids - Wikipedia

   en.wikipedia.org/wiki/Omega-3_carboxylic_acids

   Omega-3 carboxylic acids are used in addition to changes in diet to reduce triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia. [6]Intake of large doses (2.0 to 4.0 g/day) of long-chain omega-3 fatty acids as prescription drugs or dietary supplements are generally required to achieve significant (> 15%) lowering of triglycerides, and at those doses the effects can be ...

5. Some Fish Oil Doesn't Help Some Patients in Some Countries - AOL

   www.aol.com/news/2013-05-22-some-fish-oil-doesnt...

   The recommended dose for GlaxoSmithKline's prescription-grade fish oil Lovaza is 4 grams. Ditto for Amarin's Vascepa. ... Vascepa is highly purified EPA, which decreased LDL cholesterol levels by ...

6. Fish oil supplements may raise risk of stroke, heart issues ...

   www.aol.com/fish-oil-supplements-may-cause...

   Instead, prescription versions of fish oil, such as Vascepa and Lovaza, are used to counter such risk factors such as high triglycerides, a type of blood fat, in people with cardiovascular disease ...

7. Science Amarin Investors Need to Know - AOL

   www.aol.com/2012/11/09/science-amarin-investors...

   Amarin's (NAS: AMRN) new triglyceride-lowering drug, Vascepa, could have major advantages for patients over its main competitor -- GlaxoSmithKline's (NYS: GSK) Lovaza -- since one of Lovaza's ...

8. Fish oil - Wikipedia

   en.wikipedia.org/wiki/Fish_oil

   As of 2019, the US Food and Drug Administration (FDA) has approved four fish oil-based prescription drugs, namely Lovaza, Omtryg (both omega-3 acid ethyl esters), Vascepa (ethyl eicosapentaenoic acid), and Epanova (omega-3 carboxylic acids). [8] None of these drugs are actually fish oil; they are all derivatives of acids found in fish oil.

9. Does Amarin Need the FDA to Play NCE? - AOL

   www.aol.com/2012/11/08/does-amarin-need-the-fda...

   Amarin (NAS: AMRN) received Food and Drug Administration approval in July for Vascepa, its first drug to market. The treatment for severely high triglyceride levels has proven to be more effective ...